Host Restriction of Salmonella enterica Serotype Typhi Is Not Caused by Functional Alteration of SipA, SopB, or SopD

Department of Medical Microbiology and Immunology, School of Medicine, University of California at Davis, One Shields Ave., Davis, CA 95616-8645, USA.
Infection and Immunity (Impact Factor: 3.73). 01/2006; 73(12):7817-26. DOI: 10.1128/IAI.73.12.7817-7826.2005
Source: PubMed


Salmonella enterica serotype Typhi is a strictly human adapted pathogen that does not cause disease in nonprimate vertebrate hosts, while Salmonella enterica serotype Typhimurium is a broad-host-range pathogen. Serotype Typhi lacks some of the proteins (effectors) exported by the invasion-associated type III secretion system that are required by serotype Typhimurium for eliciting fluid secretion and inflammation in bovine ligated ileal loops. We investigated whether the remaining serotype Typhi effectors implicated in enteropathogenicity (SipA, SopB, and SopD) are functionally exchangeable with their serotype Typhimurium homologues. Serotype Typhi elicited fluid accumulation in bovine ligated ileal loops at levels similar to those elicited by a noninvasive serotype Typhimurium strain (the sipA sopABDE2 mutant) or by sterile culture medium. However, introduction of the cloned serotype Typhi sipA, sopB, and sopD genes complemented the ability of a serotype Typhimurium sipA sopABDE2 mutant to elicit fluid secretion in bovine ligated ileal loops. Introduction of the cloned serotype Typhi sipA, sopB, and sopD genes increased the invasiveness of a serotype Typhimurium sipA sopABDE2 mutant for human colon carcinoma epithelial (HT-29 and T84) cells and bovine kidney (MDBK) cells. Translational fusions between the mature TEM-1 beta-lactamase reporter and SipA or SopD demonstrated that serotype Typhi translocates these effectors into host cells. We conclude that the inability of serotype Typhi to cause fluid accumulation in bovine ligated ileal loops is not caused by a functional alteration of its SipA, SopB, and SopD effector proteins with respect to their serotype Typhimurium homologues.

Download full-text


Available from: Manuela Raffatellu, Oct 10, 2015
19 Reads
  • Source
    • "An important caveat concerning most of the information on Salmonella virulence and infection is that it is based on in vitro studies, carried out with a restricted number of Salmonella strains, and primarily assessed in mouse models of infection, with a limited amount of data gathered in farm animals, particularly cattle and chicken. We predict that host-dependent colonization is not only modulated by specific adhesin alleles (Guo et al., 2009; Kuzminska-Bajor et al., 2012), but also by non-synonymous SNPs in additional virulence factors, such as the T3SS effectors (Schlumberger et al., 2003; Hopkins and Threlfall, 2004; Raffatellu et al., 2005; Thornbrough and Worley, 2012). It is also likely that numerous additional Salmonella protein alleles will be identified in the near future as virulence factors senso lato, including proteins of metabolic pathways that have evolved to take advantage of unique host species properties. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Salmonella enterica causes substantial morbidity and mortality in humans and animals. Infection and intestinal colonization by S. enterica requires virulence factors that mediate bacterial binding and invasion of enterocytes and innate immune cells. Some S. enterica colonization factors and their alleles are host restricted, suggesting a potential role in regulation of host specificity. Recent data also suggest that colonization factors promote horizontal gene transfer (HGT) of antimicrobial resistance genes by increasing the local density of Salmonella in colonized intestines. Although a profusion of genes are involved in Salmonella pathogenesis, the relative importance of their allelic variation has only been studied intensely in the type 1 fimbrial adhesin FimH. Although other Salmonella virulence factors demonstrate allelic variation, their association with specific metadata (e.g. host species, disease or carrier state, time and geographic place of isolation, antibiotic resistance profile, etc.) remains to be interrogated. To date, genome-wide association studies (GWAS) in bacteriology have been limited by the paucity of relevant metadata. In addition, due to the many variables amid metadata categories, a very large number of strains must be assessed to attain statistically significant results. However, targeted approaches in which genes of interest (e.g. virulence factors) are specifically sequenced alleviates the time-consuming and costly statistical GWAS analysis and increases statistical power, as larger numbers of strains can be screened for nonsynonynmous SNPs that are associated with available metadata. Congruence of specific allelic variants with specific metadata from strains that have a relevant clinical and epidemiological history will help to prioritize functional wet-lab and animal studies aimed at determining cause-effect relationships. Such an approach should be applicable to other pathogens that are being collected in well-curated repositories.
    Frontiers in Microbiology 01/2014; 4:419. DOI:10.3389/fmicb.2013.00419 · 3.99 Impact Factor
  • Source
    • "DNA fragments coding for VceC, VceA, BtpA (1-275), and BtpB (1-292) were amplified by PCR, digested with XbaI and PstI and cloned into pFlagTEM1 (Raffatellu et al., 2005). Primers sequences with XbaI and PstI sites (underlined) are: VceC-Fw: 5′-tcctctagagaacgttcagagcgtccagaa-3′; VceC-Rv: 5′-aaactgcagctaattgcgggtttctcccttg-3′; VceA-Fw: 5′-tcctctagaaaaatcatcatcacggcagca-3′; VceA-Rv: 5′-aaactgcagctagttcttgggcgcgtggcc-3′; BtpA-Fw: 5′- tcctctagaagttcgtactcttctaatatt-3′; BtpA-Rv: 5′- aaactgcagtcagataagggaatgcagttc-3′; BtpB-Fw: 5′- tcctctagatacaatttatttgtttcgggc-3′; BtpB-Rv: 5′- aaactgcagctaggtgatgagggcgacgcg-3′. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Several bacterial pathogens have TIR domain-containing proteins that contribute to their pathogenesis. We identified a second TIR-containing protein in Brucella spp. that we have designated BtpB. We show it is a potent inhibitor of TLR signaling, probably via MyD88. BtpB is a novel Brucella effector that is translocated into host cells and interferes with activation of dendritic cells. In vivo mouse studies revealed that BtpB is contributing to virulence and control of local inflammatory responses with relevance in the establishment of chronic brucellosis. Together, our results show that BtpB is a novel Brucella effector that plays a major role in the modulation of host innate immune response during infection.
    Frontiers in Cellular and Infection Microbiology 07/2013; 3:28. DOI:10.3389/fcimb.2013.00028 · 3.72 Impact Factor
  • Source
    • "Broad-host range vector confers Amp R Kovach et al., 1995 pFlagTEM1 Cloning vector to express flagged TEM1 (FT) fusion under control of trc promoter, Cm R Raffatellu et al., 2005 pCydX/FT Expresses CydX::FT from trc promoter, Cm R This study pFT/CydX Expresses FT::CydX from trc promoter, Cm R This study pGST/FT Expresses GST::FT from trc promoter, Cm R Raffatellu et al., 2005 pFT/GST Expresses FT::GST fromtrc promoter, "
    [Show abstract] [Hide abstract]
    ABSTRACT: A large number of hypothetical genes potentially encoding small proteins of unknown function are annotated in the Brucella abortus genome. Individual deletion of 30 of these genes identified four mutants, in BAB1_0355, BAB2_0726, BAB2_0470, and BAB2_0450 that were highly attenuated for infection. BAB2_0726, an YbgT-family protein located at the 3' end of the cydAB genes encoding cytochrome bd ubiquinal oxidase, was designated cydX. A B. abortus cydX mutant lacked cytochrome bd oxidase activity, as shown by increased sensitivity to H(2)O(2), decreased acid tolerance and increased resistance to killing by respiratory inhibitors. The C terminus, but not the N terminus, of CydX was located in the periplasm, suggesting that CydX is an integral cytoplasmic membrane protein. Phenotypic analysis of the cydX mutant, therefore, suggested that CydX is required for full function of cytochrome bd oxidase, possibly via regulation of its assembly or activity.
    Frontiers in Cellular and Infection Microbiology 04/2012; 2:47. DOI:10.3389/fcimb.2012.00047 · 3.72 Impact Factor
Show more